{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:21:43Z","timestamp":1769206903315,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["819707"],"award-info":[{"award-number":["819707"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12920-019-0528-1","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T14:03:51Z","timestamp":1558533831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Next-generation sequencing for identifying a novel\/de novo pathogenic variant in a Mexican patient with cystic fibrosis: a case report"],"prefix":"10.1186","volume":"12","author":[{"given":"Ang\u00e9lica","family":"Mart\u00ednez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julieta","family":"Larrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Barajas-Olmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Garc\u00eda-Ort\u00edz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvia C.","family":"Mendoza-Caamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Contreras-Cubas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh","family":"Mirzaeicheshmeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Lezana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"528_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jcf.2016.05.007","volume":"15","author":"LVRF Silva Filho","year":"2016","unstructured":"Silva Filho LVRF, Casta\u00f1os C, Ru\u00edz HH. Cystic fibrosis in Latin America improving the awareness. J Cyst Fibros. 2016;15:791\u20133.","journal-title":"J Cyst Fibros"},{"key":"528_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2015","unstructured":"Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16:45\u201356.","journal-title":"Nat Rev Genet"},{"key":"528_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/jmedgenet-2016-103985","volume":"54","author":"V Terlizzi","year":"2017","unstructured":"Terlizzi V, Castaldo G, Salvatore D, Lucarelli M, Raia V, Angioni A, et al. Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles. J Med Genet. 2017;54:224\u201335.","journal-title":"J Med Genet"},{"key":"528_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jmoldx.2016.02.007","volume":"18","author":"M Lucarelli","year":"2016","unstructured":"Lucarelli M, Bruno SM, Pierandrei S, Ferraguti G, Testino G, Truglio G. The impact on genetic testing of mutational patterns of CFTR gene in different clinical macrocategories of cystic fibrosis. J Mol Diagn. 2016;18:554\u201365.","journal-title":"J Mol Diagn"},{"key":"528_CR5","first-page":"546","volume":"62","author":"M Ch\u00e1vez-Salda\u00f1a","year":"2010","unstructured":"Ch\u00e1vez-Salda\u00f1a M, Yokoyama E, Lezana JL, Carnevale A, Mac\u00edas M, Vigueras RM, et al. CFTR allelic heterogeneity in Mexican patients with cystic fibrosis: implications for molecular screening. Rev Investig Clin. 2010;62:546\u201352.","journal-title":"Rev Investig Clin"},{"key":"528_CR6","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/ppul.23774","volume":"52","author":"LM Nunes","year":"2017","unstructured":"Nunes LM, Ribeiro R, Niewiadonski VDT, Sabino E, Yamamoto GL, Bertola DR, et al. A new insight into CFTR allele frequency in Brazil through next generation sequencing. Pediatr Pulmonol. 2017;52:1300\u20135.","journal-title":"Pediatr Pulmonol"},{"key":"528_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clinbiochem.2015.10.007","volume":"49","author":"X Pepermans","year":"2016","unstructured":"Pepermans X, Mellado S, Chialina S, Wagener M, Gallardo L, Lande H, et al. Identification and frequencies of cystic fibrosis mutations in Central Argentina. Clin Biochem. 2016;49:154\u201360.","journal-title":"Clin Biochem"},{"key":"528_CR8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan JR, Rommens JM, Kerem B, NO a A, Rozmahel R, Grzelczak Z, et al. Identification the cystic fibrosis Gene\u00a0: cloning and characterization of complementary DNA. Science. 1989;245:1066\u201373.","journal-title":"Science."},{"key":"528_CR9","first-page":"13","volume":"11","author":"M Ivanov","year":"2018","unstructured":"Ivanov M, Matsvay A, Glazova O, Krasovskiy S, Usacheva M, Amelina E, et al. Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis. BMC Med Genet. 2018;11:13.","journal-title":"BMC Med Genet"},{"key":"528_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/0888-7543(91)90092-S","volume":"11","author":"MB White","year":"1991","unstructured":"White MB, Leppert M, Nielsen D, Zielenski J, Gerrard B, Stewart C, et al. A de novo cystic fibrosis mutation: CGA (Arg) to TGA (stop) at codon 851 of the CFTR gene. Genomics. 1991;11:778\u20139.","journal-title":"Genomics."},{"key":"528_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s004390050171","volume":"98","author":"L Cremonesi","year":"1996","unstructured":"Cremonesi L, Cainarca S, Rossi A, Padoan R, Ferrari M. Detection of a de novo R1066H mutation in an Italian patient affected by cystic fibrosis. Hum Genet. 1996;98:119\u201321.","journal-title":"Hum Genet"},{"key":"528_CR12","doi-asserted-by":"crossref","unstructured":"Casals T, Ramos MD, Gim\u00e9nez J, Nadal M, Nunes V, Estivill X. Paternal origin of a de novo novel CFTR mutation (L1065R) causing cystic fibrosis. Hum Mutat. 1988;(Suppl 1):S99-102.","DOI":"10.1002\/humu.1380110133"},{"key":"528_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jcf.2012.12.002","volume":"12","author":"P K\u0159enkov\u00e1","year":"2013","unstructured":"K\u0159enkov\u00e1 P, Pisk\u00e1\u010dkov\u00e1 T, Holubov\u00e1 A, Bala\u0161\u010dakov\u00e1 M, Kruli\u0161ov\u00e1 V, \u010camajov\u00e1 J, et al. Distribution of CFTR mutations in the Czech population: positive impact of integrated clinical and laboratory expertise, detection of novel\/de novo alleles and relevance for related\/derived populations. J Cyst Fibros. 2013;12:532\u20137.","journal-title":"J Cyst Fibros"},{"key":"528_CR14","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S1569-1993(08)60026-0","volume":"7","author":"E Girodon","year":"2008","unstructured":"Girodon E, Des georges M, Medina R, Grenet D, F\u00e9rec C, Claustres M, et al. Ocurrence of CFTR de novo mutations is not so rare. J Cyst Fibros. 2008;7:S6.","journal-title":"J Cyst Fibros"},{"key":"528_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jpeds.2011.04.022","volume":"159","author":"A Norek","year":"2011","unstructured":"Norek A, Stremska M, Sobczy\u0144ska-Tomaszewska A, Wertheim-Tysarowska K, Dme\u0144ska H, Jurek M. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype. J Pediatr. 2011;159:343\u20136.","journal-title":"J Pediatr"},{"key":"528_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s004390051051","volume":"106","author":"L Orozco","year":"2000","unstructured":"Orozco L, Vel\u00e1zquez R, Zielenski J, Tsui LC, Ch\u00e1vez M, Lezana JL, Salda\u00f1a Y, Hern\u00e1ndez E, Carnevale A. Spectrum of CFTR mutations in Mexican cystic fibrosis patients: identification of five novel mutations (W1089C, 846delT, P750L, 4160insGGGG and 297-1G--A). Hum Genet. 2000;106:360\u20135.","journal-title":"Hum Genet"},{"key":"528_CR17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1515\/cclm-2017-0553","volume":"56","author":"A Bergougnoux","year":"2018","unstructured":"Bergougnoux A, D'Argenio V, Sollfrank S, Vermeau F, Telese A, et al. Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology. Clin Chem Lab Med. 2018;56:1046\u201353.","journal-title":"Clin Chem Lab Med"},{"key":"528_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ejhg.2008.136","volume":"17","author":"E Dequeker","year":"2009","unstructured":"Dequeker E, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders \u2013 updated European recommendations. Eur J Hum Genet. 2009;17:51\u201365.","journal-title":"Eur J Hum Genet"},{"key":"528_CR19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/clinchem\/37.5.753","volume":"37","author":"KJ Friedman","year":"1991","unstructured":"Friedman KJ, Edward Highsmith W, Silverman LM. Detecting multiple cystic fibrosis mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin Chem. 1991;37:753\u20135.","journal-title":"Clin Chem"},{"key":"528_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ajmg.1320510210","volume":"15","author":"L Orozco","year":"1994","unstructured":"Orozco L, Friedman K, Ch\u00e1vez M, Lezana JL, Villareal MT, Carnevale A. Identification of the I507 deletion by site-directed mutagenesis. Am J Med Genet. 1994;15:137\u20139.","journal-title":"Am J Med Genet"},{"key":"528_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl variant effect predictor. Genome Biol. 2016;17:1\u201314.","journal-title":"Genome Biol"},{"key":"528_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/humu.23276","volume":"38","author":"M Claustres","year":"2017","unstructured":"Claustres M, Th\u00e8ze C, des Georges M, Baux D, Girodon E, Bienvenu T, et al. CFTR-France, a national relational patient database for sharing genetic and phenotypic data associated with rare CFTR variants. Hum Mutat. 2017;38:1297\u2013315.","journal-title":"Hum Mutat"},{"key":"528_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jmoldx.2017.06.002","volume":"19","author":"M Lucarelli","year":"2017","unstructured":"Lucarelli M, Porcaro L, Biffignandi A, Costantino I, Gionnone V, et al. A new targeted CFTR mutation panel based on next-generation sequencing technology. J Mol Diagn. 2017;19:788\u2013800.","journal-title":"J Mol Diagn."},{"key":"528_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nrg3241","volume":"13","author":"JA Veltman","year":"2012","unstructured":"Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet. 2012;13:565\u201375.","journal-title":"Nat Rev Genet."},{"key":"528_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/hmg\/3.4.657","volume":"3","author":"T Shoshanl","year":"1994","unstructured":"Shoshanl T, Augarten A, Yahav J, Gazit E, Kerem B. Two novel mutations in the CFTR gene: W1089X in exon 17B and 4010delTATT in exon 21. Hum Mol Genet. 1994;3:657\u20138.","journal-title":"Hum Mol Genet"},{"key":"528_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejmg.2006.04.003","volume":"49","author":"R Kellermayer","year":"2006","unstructured":"Kellermayer R. Translational readthrough induction of pathogenic nonsense mutations. Eur J Med Genet. 2006;49:445\u201350.","journal-title":"Eur J Med Genet"},{"key":"528_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ccr3.760","volume":"5","author":"A Hinzpeter","year":"2017","unstructured":"Hinzpeter A, Reboul MP, Callebaut I, Zordan C, Costes B, Guichoux J, et al. The importance of functional test to assess the effect of a new CFTR variant when genotype-phenotype correlation is not possible. Clin Case Rep. 2017;5:658\u201363.","journal-title":"Clin Case Rep"},{"key":"528_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jcf.2013.02.007","volume":"12","author":"N Altamura","year":"2013","unstructured":"Altamura N, Castaldo R, Finotti A, Breveglieri G, Salvatori F, et al. Tobramycin is a suppressor of premature termination codons. J Cyst Fibrosis. 2013;12:806\u201311.","journal-title":"J Cyst Fibrosis"},{"key":"528_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164212","volume":"11","author":"SL Girard","year":"2016","unstructured":"Girard SL, Bourassa CV, Lemieux Perreault L-P, Legault M-A, Barhdadi A, Ambalavanan A, et al. Paternal age explains a major portion of De novo germline mutation rate variability in healthy individuals. PLoS One. 2016;11:e0164212.","journal-title":"PLoS One"},{"key":"528_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ng.3469","volume":"48","author":"R Rahbari","year":"2016","unstructured":"Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Al Turki S, et al. Timing, rates and spectra of human germline mutation. Nat Genet. 2016;48:126\u201333.","journal-title":"Nat Genet"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0528-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-019-0528-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0528-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T23:25:57Z","timestamp":1590017157000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-019-0528-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["528"],"URL":"https:\/\/doi.org\/10.1186\/s12920-019-0528-1","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data collection and molecular analysis were approved by the Research and Ethics Committees at Instituto Nacional de Medicina Gen\u00f3mica (INMEGEN).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The parents signed a letter of consent to participate in the study and all children assented. They also gave their authorization for the publication of the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"68"}}